Klein Law Firm Reminds Investors of Class Actions on Behalf of TAL, MP and CABA Shareholders

NEW YORK, NY/ACCESSWIRE/March 2, 2022/ Klein Law Firm announces that class action lawsuits have been filed on behalf of shareholders of the following companies. There is no cost to participate in the costume. If you have suffered a claim, you have until the principal plaintiff’s deadline to ask the court to name you as the principal plaintiff.

Tal Education Group (NYSE: TAL)
Class period: April 26, 2018 – July 22, 2021
Lead Applicant Deadline: April 5, 2022

The Complaint alleges that, during the Class Period, Tal Education Group made materially false and/or misleading statements and/or failed to disclose that: (a) TAL’s revenues and operational growth were the result of misleading marketing and illicit business practices that violated Chinese laws, regulations and policies, and placed the Company at extreme risk of more drastic measures being imposed on the Company; (b) TAL had engaged in deceptive and fraudulent advertising practices, including providing false and misleading discount information designed to hide the true cost of the Company’s programs for its customers, creating false clients designed to fraudulently lure new clients to TAL programs, misrepresenting teacher qualifications and course grades, and marketing rigged promotional events; (c) TAL had challenged Chinese policies aimed at easing the burden imposed by tutoring services on students and their families, including imposing heavy advances and recurring debt repayments on course enrollees, by offering courses designed to giving wealthy students unfair advantages, by holding classes outside authorized tutoring hours and tying for-profit classes to government-mandated education; (d) as a result of the foregoing, TAL was subject to an undisclosed tail risk of adverse enforcement action, regulatory fines and penalties, and the imposition of new rules and regulations adverse to business and financial interests of the society ; and (e) as a result of the foregoing, TAL’s historic growth was not sustainable or resulted from legitimate business tactics as depicted, and defendants’ positive statements about the businesses, operations and prospects of company were materially false and misleading and lacked a reasonable factual basis.

Learn more about your recoverable losses in TAL: https://www.kleinstocklaw.com/pslra-1/tal-education-group-loss-submission-form?id=24243&from=1

MP Materials Corp. f/k/a Fortress Value Acquisition Corp. (NYSE:MP)
Class period: May 1, 2020 – February 2, 2022
Lead Applicant Deadline: April 25, 2022

According to the complaint, MP Materials Corp. f/k/a Fortress Value Acquisition Corp. allegedly made materially false and/or misleading statements and/or failed to disclose that: (i) Fortress Value Acquisition Corp. (“FVAC”) had overestimated its due diligence efforts and its expertise in identifying target companies to acquire; (ii) FVAC performed inadequate due diligence on Legacy MP Materials prior to the business combination, or ignored important red flags regarding, among other things, Legacy MP Materials’ management, compliance policies and profitability of Mountain Pass; (iii) as a result, the future business and financial prospects of the Company after the business combination were overstated; (iv) MP Materials engaged in an abusive transfer pricing scheme with a related party in the People’s Republic of China to artificially inflate the Company’s profits; (v) MP Materials ore at the Mountain Pass rare earth mine and processing facility was not economically viable to harvest for rare earth metals; and (vi) as a result, the Company’s public statements were materially false and misleading at all material times.

Learn more about your recoverable losses in MP: https://www.kleinstocklaw.com/pslra-1/mp-materials-corp-fka-fortress-value-acquisition-corp-loss-submission-form?id=24243&from=1

Cabaletta Bio, Inc. (NASDAQ: CABA)
This lawsuit is on behalf of persons and entities that have purchased or otherwise acquired: (a) common stock of Cabaletta pursuant to and/or documents issued in connection with the Company’s completed initial public offering on or around October 24, 2019; and/or (b) Cabaletta securities between October 24, 2019 and December 13, 2021, both dates inclusive.
Lead Applicant Deadline: April 29, 2022

The CABA lawsuit alleges that Cabaletta Bio, Inc. made materially false and/or misleading statements and/or failed to disclose during the Class Period that: (i) primary data from the Phase 1 clinical trial reported that Cabaletta’s lead product candidate, DSG3-CAART, among other things, worsened some participants’ disease activity scores and required additional systemic medication to improve disease activity after infusion of DSG3- CAART; (ii) as a result, DSG3-CAART was not as effective as the Company had represented it to investors; (iii) therefore, the Company had exaggerated the clinical and/or commercial prospects of DSG3-CAART; and (iv) as a result, the Company’s public statements were materially false and misleading at all material times.

Find out about your recoverable losses in CABA: https://www.kleinstocklaw.com/pslra-1/cabaletta-bio-inc-loss-submission-form?id=24243&from=1

Your ability to participate in any collection does not require you to serve as the lead plaintiff. If you have suffered a loss during the course period and would like additional information, please contact J. Klein, Esq. by phone at 212-616-4899 or visit the web pages provided.

J. Klein, Esq. represents investors and participates in securities litigation involving financial fraud across the country. Lawyer advertisement. Prior results do not guarantee similar results.

J. Klein, Esq.
Empire State Building
350 Fifth Avenue
59th floor
New York, NY 10118
[email protected]
Telephone: (212) 616-4899
Fax: (347) 558-9665

THE SOURCE: Klein law firm

See the source version on accesswire.com: